Literature DB >> 21154745

Xylitol inhibits carcinogenic acetaldehyde production by Candida species.

Johanna Uittamo1, Mikko T Nieminen, Pertti Kaihovaara, Paul Bowyer, Mikko Salaspuro, Riina Rautemaa.   

Abstract

Acetaldehyde is a highly toxic and mutagenic product of alcohol fermentation and metabolism which has been classified as a Class I carcinogen for humans by the International Agency for Research on Cancer of the World Health Organisation (WHO). Many Candida species representing oral microbiota have been shown to be capable of marked acetaldehyde production. The aim of our study was to examine the effects of various sugar alcohols and sugars on microbial acetaldehyde production. The study hypothesis was that xylitol could reduce the amount of acetaldehyde produced by Candida. Laboratory and clinical isolates of seven Candida species were selected for the study. The isolates were incubated in 12 mM ethanol and 110 mM glucose, fructose or xylitol at 37°C for 30 min and the formed acetaldehyde was measured by gas chromatography. Xylitol significantly (p < 0.0001) reduced the amount of acetaldehyde produced from ethanol by 84%. In the absence of xylitol, the mean acetaldehyde production in ethanol incubation was 220.5 μM and in ethanol-xylitol incubation 32.8 μM. This was found to be mediated by inhibition of the alcohol dehydrogenase enzyme activity. Coincubation with glucose reduced the amount of produced acetaldehyde by 23% and coincubation with fructose by 29%. At concentrations that are representative of those found in the oral cavity during the intake of proprietary xylitol products, xylitol was found to reduce the production of carcinogenic acetaldehyde from ethanol by Candida below the mutagenic level of 40-100 μM.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21154745     DOI: 10.1002/ijc.25844

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro.

Authors:  Mikko T Nieminen; Lily Novak-Frazer; Vilma Rautemaa; Ranjith Rajendran; Timo Sorsa; Gordon Ramage; Paul Bowyer; Riina Rautemaa
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

2.  Fanconi anemia: young patients at high risk for squamous cell carcinoma.

Authors:  Eunike Velleuer; Ralf Dietrich
Journal:  Mol Cell Pediatr       Date:  2014-11-01

Review 3.  Therapeutic Application of Synbiotics, a Fusion of Probiotics and Prebiotics, and Biogenics as a New Concept for Oral Candida Infections: A Mini Review.

Authors:  Tomoko Ohshima; Yukako Kojima; Chaminda J Seneviratne; Nobuko Maeda
Journal:  Front Microbiol       Date:  2016-01-25       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.